NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 856.00
+26.00 (3.13%)
At close: Nov 13, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 13.77 billion as of November 13, 2026. It is the 41,319th most valuable company in the world and the 2,560th biggest in South Korea. Its market cap has decreased by 63.34% in one year.
Market Cap
13.77B
Enterprise Value
43.15B
Revenue
41.80B
Global Rank
Country Rank
#2,560 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 13.77B, a decrease of -95.61%. That is a compound annual growth rate of -40.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 13.77B | -62.33% |
| Dec 30, 2025 | 36.56B | 12.79% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.24% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HLB Pep | 31.88B |
| Progen | 27.43B |
| Epibiotech | 25.88B |
| ADBiotech | 20.81B |
| Poongjeon Pharmacy CO.,LTD. | 20.55B |
| Shaperon | 19.01B |
| Moogene Medi | 18.90B |
| Plumbline Life Sciences | 18.69B |